EU notified body association, TEAM-NB, has approved the so-called Notified Body Confirmation Letter. This is a critical element for manufacturers of legacy products to be able to demonstrate that they are entitled to benefit from the extension of the MDR transitional period (as introduced recently in amending regulation, 2023/607. (Also see "MDR Amending Regulation Officially Published And Already In Force" - Medtech Insight, 20 March, 2023.)
It is due to be made available on the TEAM-NB website “soon.”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?